Progress in research of ablation radiotherapy for pancreatic cancer

doi:10.3877/cma.j.issn.1674-0785.2022.12.021

Abstract

Abstract:

Because the pancreas is adjacent to the gastrointestinal tract, it is difficult to increase the dose of radiotherapy for pancreatic lesions. How to implement the ablation radiotherapy of pancreatic cancer is a challenge in the field of radiotherapy. The advent of precision radiotherapy technology in recent years opens an avenue for the application of ablative radiotherapy in pancreatic cancer. This article reviews the literature about the ablation radiotherapy of pancreatic cancer, suggesting that the development and update of radiation technology, dosage mode, and implementation provide a precondition for the ablation radiotherapy of pancreatic cancer. Dosimetry and preliminary clinical results show that ablation radiotherapy is feasible in the treatment of pancreatic cancer, and the prognosis is promising.

Key words: Pancreatic cancer, Ablation radiotherapy, Progress

Gang Ren, Guangkai Shen, Yingjie Wang. Progress in research of ablation radiotherapy for pancreatic cancer[J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(12): 1276-1279.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhlcyszz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-0785.2022.12.021

https://zhlcyszz.cma-cmc.com.cn/EN/Y2022/V16/I12/1276

References 25

1	Goto Y, Nakamura A, Ashida R, et al. Clinical evaluation of intensity-modulated radiotherapy for locally advanced pancreatic cancer [J]. Radiat Oncol, 2018; 13(1): 118.
2	Taylor R, Opfermann K, Jones BD, et al. Comparison of radiation treatment delivery for pancreatic cancer: Linac intensity-modulated radiotherapy versus helical tomotherapy [J]. J Med Imaging Radiat Oncol, 2012, 56(3): 332-337.
3	Dai ZT, Ma L, Cao TT, et al. Dosimetric and radiobiological comparison of treatment plan between CyberKnife and EDGE in stereotactic body radiotherapy for pancreatic cancer [J]. Sci Rep, 2021, 11(1): 4065.
4	Raturi VP, Tochinai T, Hojo H, et al. Dose-volume and radiobiological model-bbased comparative evaluation of the gastrointestinal toxicity risk of photon and proton irradiation plans in localized pancreatic cancer without distant metastasis [J]. Front Oncol, 2020, 10: 517061.
5	Stefanowicz S, Wlodarczyk W, Frosch S, et al. Dose-escalated simultaneously integrated boost photon or proton therapy in pancreatic cancer in an in-silico study: Gastrointestinal organs remain critical [J]. Clin Transl Radiat Oncol, 2020, 27: 24-31.
6	Liermann J, Naumann P, Hommertgen A, et al. Carbon ion radiotherapy as definitive treatment in non-metastasized pancreatic cancer: study protocol of the prospective phase II PACK-study [J]. BMC Cancer, 2020, 20(1): 947.
7	滕峰, 朱夫海, 任刚. 胰腺癌立体定向放疗中腹部危及器官解剖变化对剂量学的影响 [J]. 中日友好医院学报, 2021, 35(3): 150-153, 后插1.
8	Magallon-Baro A, Granton PV, Milder MTW, et al. A model-based patient selection tool to identify who may be at risk of exceeding dose tolerances during pancreatic SBRT [J]. Radiother Oncol, 2019, 141: 116-122.
9	Magallon-Baro A, Milder MTW, Granton PV, et al. Comparison of daily online plan adaptation strategies for a cohort of pancreatic cancer patients treated with SBRT [J]. Int J Radiat Oncol Biol Phys, 2021, 111(1): 208-219.
10	Tchelebi LT, Zaorsky NG, Rosenberg JC, et al. Reducing the toxicity of radiotherapy for pancreatic cancer with magnetic resonance-guided radiotherapy [J]. Toxicol Sci, 2020, 175(1): 19-23.
11	Placidi L, Romano A, Chiloiro G, et al. On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations [J]. Tech Innov Patient Support Radiat Oncol, 2020, 15: 15-21.
12	Patel JB, Revanur V, Forcione DG, et al. Endoscopic ultrasound-guided fiducial marker placement in pancreatic cancer: A systematic review and meta-analysis [J]. World J Gastrointest Endosc, 2020, 12(8): 231-240.
13	Kim SH, Shin EJ. Endoscopic ultrasound-guided fiducial placement for stereotactic body radiation therapy in pancreatic malignancy [J]. Clin Endosc, 2021, 54(3): 314-323.
14	Imaizumi A, Araki T, Okada H, et al. Transarterial fiducial marker implantation for CyberKnife radiotherapy to treat pancreatic cancer: an experience with 14 cases [J]. Jpn J Radiol, 2021, 39(1): 84-92.
15	Pollom EL, Alagappan M, von Eyben R, et al. Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity [J]. Int J Radiat Oncol Biol Phys, 2014, 90(4): 918-925.
16	Tchelebi LT, Lehrer EJ, Trifiletti DM, et al. Conventionally fractionated radiation therapy versus stereotactic body radiation therapy for locally advanced pancreatic cancer (CRiSP): An international systematic review and meta-analysis [J]. Cancer, 2020, 126(10): 2120-2131.
17	Teng F, Meng L, Zhu F, et al. Dosimetric feasibility on hypofractionated intensity-modulated radiotherapy and simultaneous integrated boost for locally advanced unresectable pancreatic cancer with helical tomotherapy [J]. J Gastrointest Oncol, 2021, 12(2): 496-506.
18	Mazzarotto R, Simoni N, Guariglia S, et al. Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to Raise the Bar [J]. Front Oncol, 2020, 10: 600940.
19	Rao AD, Shin EJ, Meyer J, et al. Evaluation of a novel absorbable radiopaque hydrogel in patients undergoing image guided radiation therapy for borderline resectable and locally Advanced pancreatic adenocarcinoma [J]. Pract Radiat Oncol, 2020, 10(6): e508-e513.
20	Lee D, Komatsu S, Terashima K, et al. Surgical spacer placement for proton radiotherapy in locally advanced pancreatic body and tail cancers: initial clinical results [J]. Radiat Oncol, 2021, 16(1): 3.
21	Kawaguchi H, Demizu Y, Mukumoto N, et al. Efficacy of spacers in radiation therapy for locally advanced pancreatic cancer: a planning study [J]. Anticancer Res, 2021, 41(1): 503-508.
22	Wang J, Xia T, Wang Y, et al. Long-term results of gamma ray-based stereotactic body radiotherapy in treatment of medically unfit or inoperable non-metastatic pancreatic adenocarcinoma [Abstract 3587] [J]. Int J Radiat Oncol, Bio, Phy, 2012, 84(Suppl. 3): S815-S816.
23	Henke LE, Olsen JR, Contreras JA, et al. Stereotactic MR-guided online adaptive radiation therapy (SMART) for ultracentral thorax malignancies: results of a phase 1 trial [J]. Adv Radiat Oncol, 2018, 4(1): 201-209.
24	Rossi G, Simoni N, Paiella S, et al. Risk adapted ablative radiotherapy after intensive chemotherapy for locally advanced pancreatic cancer [J]. Front Oncol, 2021, 11: 662205.
25	Reyngold M, O'Reilly EM, Varghese AM, et al. Association of ablative radiation therapy with survival among patients with inoperable pancreatic cancer [J]. JAMA Oncol, 2021, 7(5): 735-738.

[1]	Yongbo Zhang, Liang Zhang, Liuyang Chen, Rui Dai, Hua Sun, Sheng Yang, Bo Meng, Qing Peng. Mitochondrial and intervertebral disc degeneration [J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2023, 18(03): 265-269.
[2]	Yijun Fan, Feng Yang, Wei Wang, Heying Yin, Jun Liu. Research progress in the diagnostic and therapeutic value of Delphian lymph node metastasis in papillary thyroid carcinoma [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(04): 306-310.
[3]	Xiyan Zheng, Zheng Zhou, Fangping He, Zhiqun Lin, Fei Du, Qin Xie, Shaoping Wang, Xianjie Shi. Risk factors for the prognosis of metabolic syndrome and hepatitis B virus related hepatocellular carcinoma [J]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(02): 104-109.
[4]	Peizhong Shang, Runping Zhang, Wei Zhang, Guohong Jia, Xiaowu Li, Jianjun Miao, Bing Liu. Clinical application of novel techniques for obstructive jaundice prevention and treatment: a single-center study [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(01): 104-107.
[5]	Huiling Long, Mi Lin, Ting Shao. Research progress and application of three-dimensional spherical mesenchymal stem cell culture technology [J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2023, 13(04): 229-234.
[6]	Fuhao Qin, Zheng Zheng, Bin Jiang. Research progress of mesenchymal stem cells in the treatment of perianal fifistulizing Crohn's disease [J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2023, 13(03): 172-177.
[7]	Bing Lan, Huaiming Wang, Hui Wang, Bo Ma. Research progress on locally advanced colon cancer with bladder invasion [J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2023, 12(06): 505-511.
[8]	Jiafa Ren, Buyun Wu, Changying Xing, Huijuan Mao. Advances in the basic and clinical research on acute kidney injury in 2022 [J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2023, 12(05): 276-281.
[9]	Jiawei He, Liang Zhang, Qi Yang, Zhanxiang Wang. Current status of diagnosis and treatment of progressive hemorrhagic injury after traumatic brain injury [J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2023, 09(03): 175-179.
[10]	Hengyu Luan, Xiaoyong Sai. Treatment status and research progress of post-traumatic stress disorder [J]. Chinese Journal of Neurotraumatic Surgery(Electronic Edition), 2023, 09(02): 112-118.
[11]	Kunqi Zhang, Rui Zhang, Jia Xu, Qinglin Kang. The progress of the management of floating knee injury [J]. Chinese Journal of Geriatric Orthopaedics and Rehabilitation(Electronic Edition), 2023, 09(04): 252-256.
[12]	Qiang Ma, Jun Li, Lijuan Gou. Expression levels of miR-21-3p and RUNX3 in severe acute pancreatitis and their predictive value to the progression of the disease [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(05): 337-341.
[13]	Yihan Wu, Zhang Lei, Hongda Lu. Progress in understanding of role of MUC16/CA125 in diagnosis and treatment of benign and malignant tumors [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(05): 591-595.
[14]	Wenxi Cao, Xiao Chen, Laifa Zhu, Yongping Zhou. Efficacy and safety of nituzumab combined with albumin bound paclitaxel in treatment of pancreatic cancer [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(04): 409-413.
[15]	Dandan Li, Zhijuan Cheng, Xu Liu, Weiping Chen, Min Yin, Hua Guo, Jianglong Tu. Effect of endovascular treatment on acute progressive ischemic stroke in posterior circulation [J]. Chinese Journal of Cerebrovascular Diseases(Electronic Edition), 2023, 17(02): 112-123.

Please choose a citation manager

Content to export